Evidence map›Paper›PMID 36171419›Full record

ArticleNature communications2022

TFEB regulates sulfur amino acid and coenzyme A metabolism to support hepatic metabolic adaptation and redox homeostasis.

David Matye, Sumedha Gunewardena, Jianglei Chen, Huaiwen Wang, Yifeng Wang, Mohammad Nazmul Hasan, Lijie Gu, Yung Dai Clayton, Yanhong Du, Cheng Chen and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

David MatyeHarold Hamm Diabetes Center, Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Sumedha GunewardenaDepartment of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Jianglei ChenHarold Hamm Diabetes Center, Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Huaiwen WangLaboratory for Molecular Biology and Cytometry Research, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Yifeng WangDepartment of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Mohammad Nazmul HasanHarold Hamm Diabetes Center, Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.ORCID 0000-0003-4196-0406
Lijie GuHarold Hamm Diabetes Center, Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Yung Dai ClaytonHarold Hamm Diabetes Center, Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Yanhong DuHarold Hamm Diabetes Center, Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Cheng ChenHarold Hamm Diabetes Center, Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Jacob E FriedmanHarold Hamm Diabetes Center, Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Shelly C LuKarsh Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.ORCID 0000-0003-2128-5407
Wen-Xing DingDepartment of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, 66160, USA.ORCID 0000-0002-3167-5073
Tiangang LiHarold Hamm Diabetes Center, Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA. tiangang-li@ouhsc.edu.ORCID 0000-0001-8568-0129
University of Oklahoma Health Sciences Center · USUniversity of Kansas Medical Center · USCedars-Sinai Medical Center · US

Funding

Tissue Pathology Shared ResourceP30CA225520 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michael S. Businelle · 2018 to 2026
$27.1M
Mechanisms regulating autophagy in alcohol-induced liver injuryR37AA020518 · NIAAA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Wen-Xing Ding · 2019 to 2026
$3.2M
Regulation of Bile Acid Metabolism and Signaling in Metabolic DiseasesR01DK117965 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Tiangang Li · 2019 to 2026
$2.7M
Mechanisms regulating autophagy in alcohol-induced liver injuryR01AA020518 · NIAAA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DING, WEN-XING · 2011 to 2018
$2.3M
Maternal Obesity and Pediatric NAFLD: Fetal Origins and Long-term outcomes in Non Human PrimatesR01DK128416 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI FRIEDMAN, JACOB E · 2021 to 2024
$2.3M
Role of SAMe in the Progression of Nonalcoholic Fatty Liver DiseaseR01DK123763 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI LU, SHELLY CHI-LOO · 2020 to 2024
$2.1M
Mechanisms of Impaired Lysosomal Biogenesis and Autophagy in Alcohol-Associated Alzheimer's DiseaseR01AG072895 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DING, WEN-XING · 2020 to 2024
$1.9M
Autophagy in Alcoholic PancreatitisU01AA024733 · NIAAA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DING, WEN-XING · 2017 to 2021
$1.7M
Sulfur Amino Acid Metabolism and Regulation of Hepatic Metabolic FlexibilityR01DK131064 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI LI, TIANGANG · 2022 to 2025
$1.6M
Novel mechanisms of aging-associated hyper-susceptibility to hepatotoxicity and liver injuryR21AG065720 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI LI, TIANGANG · 2020 to 2021
$409k
NCI NIH HHS P30 CA225520NIAAA NIH HHS R01 AA020518NIAAA NIH HHS R37 AA020518NIAAA NIH HHS U01 AA024733NIA NIH HHS R01 AG072895NIA NIH HHS R21 AG065720NIDDK NIH HHS R01 DK117965NIDDK NIH HHS R01 DK123763NIDDK NIH HHS R01 DK128416NIDDK NIH HHS R01 DK131064
6 · The paper itself

Abstract

Fatty liver is a highly heterogenous condition driven by various pathogenic factors in addition to the severity of steatosis. Protein insufficiency has been causally linked to fatty liver with incompletely defined mechanisms. Here we report that fatty liver is a sulfur amino acid insufficient state that promotes metabolic inflexibility via limiting coenzyme A availability. We demonstrate that the nutrient-sensing transcriptional factor EB synergistically stimulates lysosome proteolysis and methionine adenosyltransferase to increase cysteine pool that drives the production of coenzyme A and glutathione, which support metabolic adaptation and antioxidant defense during increased lipid influx. Intriguingly, mice consuming an isocaloric protein-deficient Western diet exhibit selective hepatic cysteine, coenzyme A and glutathione deficiency and acylcarnitine accumulation, which are reversed by cystine supplementation without normalizing dietary protein intake. These findings support a pathogenic link of dysregulated sulfur amino acid metabolism to metabolic inflexibility that underlies both overnutrition and protein malnutrition-associated fatty liver development.

Indexed as

Amino Acids, SulfurFatty LiverAnimalsAntioxidantsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCoenzyme ACysteineCystineDietary ProteinsGlutathioneHomeostasisLipidsLiverMethionineMethionine AdenosyltransferaseMiceAmino Acids, SulfurAntioxidantsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCoenzyme ACysteineCystineDietary ProteinsGlutathioneLipidsMethionineMethionine AdenosyltransferaseTcfeb protein, mouse

Identifiers

PMID36171419
PMCPMC9519740
OpenAlexW4297493831

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.